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ABSTRACT
Background: Traditional laparoscopic anterior rectal resec-
tion (TLAR) has recently been used for rectal cancer, offering
good functional results compared with open anterior resec-
tion and resulting in a better postoperative early outcome.
However, laparoscopic rectal resection can be technically
demanding, especially when a total mesorectal excision is
required. The aim of this study was to verify whether robot-
assisted anterior rectal resection (RLAR) could overcome
limitations of the laparoscopic approach.
Methods: Sixty-six patients with rectal cancer were en-
rolled in the study. Twenty-nine patients underwent RLAR
and 37 TLAR. Groups were matched for age, BMI, sex
ratio, ASA status, and TNM stage, and were followed up
for a mean time of 12 months.
Results: Robot-assisted laparoscopic rectal resection results
in shorter operative time when a total mesorectal excision is
performed (165.910 vs 21037 minutes; P0.05). The
conversion rate is significantly lower for RLAR (P0.05).
Postoperative morbidity was comparable between groups.
Overall survival and disease-free survival were comparable
between groups, even though a trend towards better dis-
ease-free survival in the RLAR group was observed.
Conclusion: RLAR is a safe and feasible procedure that
facilitates laparoscopic total mesorectal excision. Random-
ized clinical trials and longer follow-ups are needed to
evaluate a possible influence of RLAR on patient survival.
Key Words: Traditional laparoscopic anterior rectal re-
section, Robot-assisted laparoscopic anterior rectal resec-
tion, Rectal cancer, da Vinci Surgical System.
INTRODUCTION
Current rectal cancer treatment is based on a multidisci-
plinary approach entailing surgery, chemotherapy, and
radiotherapy. The aim of surgery is to remove the rectum
and the mesorectum contained within the intact fascia of
the rectum. This technique reduces pelvic recurrence,
prolongs survival, and preserves postoperative erectile
and urinary function by avoiding nerve injury.1,2 Laparo-
scopic anterior resection with total mesorectal excision
(TME) has been recently introduced as a treatment option
for rectal cancer.3
Oncologic outcomes of laparoscopic TME are comparable
to those of the open counterpart, and the postoperative
course showed improvement in several retrospective and
randomized controlled studies.3,4
Robot-assisted surgery is considered an evolution of tra-
ditional laparoscopy, but little data support any real ben-
efits of this technology.5
Robotic attributes improve surgeon dexterity where fine
manipulation of tissues in a close, fixed operating field or
when hand-sewn sutures and knot tying are required.6
Therefore, we believe that a robotic approach could be
relevant for laparoscopic anterior rectal resection.
To evaluate the role of robotics in rectal surgery, we
compared intra- and postoperative outcomes of anterior
resection using a traditional laparoscopic approach (tra-
ditional laparoscopic anterior resection; TLAR) and a ro-
bot-assisted procedure with the 3-arm da Vinci Surgical
System (Intuitive Surgical Inc., Sunny-vale, CA) (robot-
assisted laparoscopic anterior resection; RLAR).
MATERIALS AND METHODS
Between March 2004 and October 2008, a minimally in-
vasive approach was proposed to all patients with a his-
tologically proved rectal adenocarcinoma irrespective to
the stage of disease. Preoperative workup included phys-
ical examination, colonoscopy, total-body computed to-
mography, and blood count. Pelvic magnetic resonance
imaging was used to evaluate local infiltration, when
needed.
Department of General, Vascular, Minimally Invasive and Robotic Surgery, Hospital
San Matteo degli Infermi–Spoleto (PG), Italy (all authors).
We wish to thank Dr Luigi Maria Lapalorcia for language revision.
Address correspondence to: Alberto Patriti, MD, PhD, Department of General, Vascu-
lar, Minimally Invasive and Robotic Surgery, Hospital San Matteo degli Infermi –
Spoleto, Via Loreto 3, 06049–Spoleto (PG), Italy. Telephone: 39–0743-2101, Fax:
39–0743-2101, E-mail: albertopatriti@gmail.com
© 2009 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. Published by the
Society of Laparoendoscopic Surgeons, Inc.
JSLS (2009)13:176–183 176
SCIENTIFIC PAPERPatients preoperatively staged as T3 or T4 without distant
metastases were treated by preoperative radiochemo-
therapy (45 Gy for 4 weeks together with systemic 5-flu-
ouracil intravenous infusion) and were reevaluated with a
clinical examination and computed tomography 20 days
after treatment. Resectable synchronous liver metastases
were not considered a contraindication for a minimally
invasive approach and were treated at the same time of
the primary tumor (one-stage resection). Liver resections
were always carried out with the aid of the robotic system.
The day before surgery, patients were randomly sched-
uled for 1 of the 2 procedures. Data were collected pro-
spectively.
Clinical parameters analyzed included patient characteris-
tics, operative variables, pathologic examination, short-
term and medium-term outcomes.
Perioperative data included operative time, blood loss,
conversion rate, perioperative complications, and length
of hospital stay. Operative time was calculated as the time
between pneumoperitoneum induction and port-site clo-
sure. Intraoperative blood loss was measured by subtrac-
tion of aspirated and instilled fluids.
Pathologic examination included type, stage of disease
(TNM), number of lymph nodes harvested, and longitu-
dinal and radial margins of excision.
Patients underwent a weekly clinical examination during
the 30 days after discharge and then were followed up
every 6 months with a physical examination, tumor mark-
ers, liver ultrasound, computed tomography, chest x-ray,
and colonoscopy.
The impact of surgery on pelvic nerve preservation was
investigated by interview. Sexual function impairment
was defined as the impossibility of achieving an erection
or ejaculation after surgery. Patients with pre-existing
poor genital function were excluded from the statistical
analysis.
Operative Technique
During the study period, we performed total mesorectal
excision (TME), with transection of the rectum at the level
of the pelvic floor and removal of intact mesorectum, for
patients with mid and distal rectal cancer. For tumors of
the upper rectum or recto-sigmoid junction, transection of
the rectum and mesorectum 4cm below the lower border
of the tumor was performed following sharp perimeso-
rectal dissection (partial mesorectal excision: PME).
This approach has been demonstrated to be effective as
routine TME for all rectal cancers.1,7 In cases of very low
tumors, an intersphincteric resection with specimen ex-
traction through the anus and hand sewn coloanal anas-
tomosis was performed. Abdominoperineal resections
(APR) were proposed to patients with sphincter-invading
lesions or with very low tumors and poor fecal conti-
nence.
Laparoscopic Technique
One camera port and 3 working trocars are positioned
after CO2 pneumoperitoneum at 12mm Hg is induced
using a Veress needle. The position of the trocars is shown
in Figure 1. The patient is kept in a steep Trendelenburg
position during the whole procedure to remove the small
bowel from the pelvis. The left colon is fully mobilized by
Figure 1. Trocar position for robot-assisted anterior rectal resec-
tion and traditional laparoscopic anterior rectal resection. c:
camera port; o1 and o2: operative trocars; a1 and a2: accessory
trocars. Robotic trocars are inserted with the “trocar in trocar”
technique through trocars o1 and o2. Trocar a2 is not always
necessary.
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covered by Toldt’s fascia, after which the left ureter and
gonadal vessels are identified. Splenic flexure is not rou-
tinely mobilized. Peritoneal serosa is incised starting at the
sacral promontory. Dissection then proceeds cranially to
the origin of the inferior mesenteric artery (IMA) and
inferior mesenteric vein (IMV). IMA is divided between
clips at its origin and IMV at the level of the duodenoje-
junal flexure. The cleavage plane between the presacral
fascia and the visceral layer that underlines the mesorec-
tum is then identified at the level of the sacral promontory.
Mesorectal dissection is carried out circumferentially using
the Harmonic scalpel. Measurement of distance between
the tumor and the cutting line is performed by digital
exploration or endoscopy.
Division of the rectum is carried out with a linear endo-
scopic stapler inserted through the right iliac fossa trocar.
Proximal section of the vascular arcade and colon is per-
formed laparoscopically, and the specimen is extracted
through a left lower quadrant minilaparotomy. The anas-
tomosis is created with a mechanical circular stapler in-
serted transanally, according to the double-stapled tech-
nique. Ileostomy is not routinely performed.
Robotic Technique
We perform a hybrid technique with laparoscopic mobi-
lization of the colon and robotic-assisted mesorectal exci-
sion, as described by Pigazzi.8,9 The scrub nurse and one
on-table assistant dress the robot while pneumoperito-
neum is being established. Therefore, time for abdominal
insufflation with the Veress needle and robot docking are
superimposed.
A 12-mm camera port, two 8-mm robotic working ports,
and 2 additional laparoscopic trocars are placed as shown
in Figure 1. The patient is kept in a steep Trendelenburg
position during the whole procedure. A medial-to-lateral
dissection with high ligation of the inferior mesenteric
vein and artery near its origin is carried out laparoscopi-
cally followed by laparoscopic mobilization of descending
and sigmoid colon and of the splenic flexure, if necessary.
Thereafter the da Vinci robotic system is docked in be-
tween the patient’s legs. The 2 working arms usually carry
a Cadier forceps on the left and a hook cautery on the
right. The on-table assistant uses 2 ports for suctioning
and retraction. The dissection is continued in the fashion
of a total mesorectal excision.
Once the TME is completed, the assistant divides the distal
rectum by using a 30-mm linear stapler through the
12-mm laparoscopic port. The specimen is extracted
through a minilaparotomy on the left lower quadrant, and
the anastomosis is created as described above.
Statistical Analysis
Parametric variables are given as means  SD and were
analyzed with the Student t test.
Frequencies were analyzed with the 
2 test, and the Mann-
Whitney test was used for nonparametric data.
Survival curve analysis was carried out with the Kaplan-
Meier method, and the evaluation of differences between
the groups was performed with the log-rank test. Statisti-
cal significance was set at P0.05. Statistical analysis was
carried out using Prism 4.0.3 data analysis software for
Windows (GraphPad Software, San Diego, CA, USA).
RESULTS
Seventy-six consecutive patients were treated for rectal
cancer between March 2004 and October 2008.
A minimally invasive approach was proposed to all pa-
tients. In 7 cases, however, conversion to laparotomy was
necessary, 3 patients preferred an open approach, so they
were all excluded from the study. Patient characteristics
are summarized in Table 1. The 2 groups are matched for
age, BMI, ASA status, and TNM stage. A greater number of
low rectal cancers were deliberately treated by a robotic
approach, because after the first cases we felt a subjective
improvement in low mesorectal dissection using the da
Vinci system and randomization abandoned because
TLAR was considered disadvantageous. Moreover, the
RLAR group differs from the TLAR also for the greater
number of patients who underwent neoadjuvant chemo-
radiotherapy and patients with a history of previous ab-
dominal surgery.
Intraoperative Data
Intraoperative and pathologic data are summarized in
Table 2. As mentioned above, in the RLAR group more
patients underwent TME than in the TLAR group.
Robot-assisted operations comprising a TME (total proc-
tectomy and abdomino-perineal resection) were signifi-
cantly faster than the laparoscopic counterparts. On the
other hand, robot-assisted PME was more time consum-
ing. In the TLAR group, a conversion rate of 19% was
recorded. In the RLAR group, there were not conversions
to open surgery, but in 2 patients the planned robotic
approach was abandoned in favor of traditional laparos-
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at the preoperative workup. Blood losses were small, and
transfusions were not required in the 2 groups. A diverting
stoma was never performed. In all cases, adequate tumor-
free resection and radial margins were obtained, and the
number of lymph nodes harvested was comparable be-
tween groups (Table 2).
In both groups, concomitant procedures were carried out
but time for their execution and respective blood-loss
were not considered for statistical analysis. Stage IV pa-
tients with resectable liver metastases underwent 1-stage
resection of the primary and liver metastasis, a 1.5-cm
nodule in segment 8 and a 1.5 nodule in segment 7 in the
RLAR and TLAR groups, respectively.
RESULTS
The 30-day mortality was null, and no significant differ-
ences occurred in terms of specific complications between
the 2 groups of patients (Table 3).
Two patients in the TLAR group required postoperative
transfusion for trocar and rectal bleeding, respectively.
Both cases were treated conservatively, but the patient
with the rectal hemorrhage developed an anastomotic
fistula requiring a diverting loop-ileostomy, prolonged
antibiotic therapy, and total parenteral nutrition. Patients
in both groups scheduled for adjuvant chemoradiation or
chemotherapy alone underwent treatment one month af-
ter surgery (TLAR 7 patients, 3311 days; RLAR 9 patients,
316 days).
During the follow-up period, we did not identify differ-
ences between groups in the incidence of erectile dys-
function and fecal incontinence. Postoperative erectile
dysfunction does not seem to be correlated with the ex-
tent of mesorectal dissection. In fact, all 5 cases observed
were patients with tumors in the higher third of the rec-
tum. However, it is more likely that it is correlated with
other factors, such as the learning curve and the complex-
ity of mesorectal excision. Erectile dysfunction was re-
ported by the first 2 patients in the RLAR group and by a
patient with a bulky tumor in the TLAR group.
Concerning oncologic results, we evaluated all the 66
patients with a mean follow-up of 18.7 and 29.2 months in
the TLAR and RLAR groups, respectively.
During this period, 2 patients (3% of total patients) died of
cancer: 1 in the TLAR and 1 in the RLAR group. The local
Table 1.
Demographic Data
TLAR* RLAR* P Value
Patients 37 29
Age (years) 69  10 68  10 0.05
Sex (M:F) 1:2 1:1.6 0.05
BMI* 25.4  6.44 24  6.2 0.05
ASA Status 0.05
I2 2
II 14 13
III 21 14
Previous Surgery 11 18 0.01
Neoadjuvant Chemoradiotherapy 2 7 0.05
Tumor Location (cm from anal verge) 11  4.5 5.9  4.2 0.01
TNM Stage 0.05
I1 7 1 1
II 8 9
III 10 7
IV 2 2
*BMI  Body Mass Index; TLAR  Traditional laparoscopic anterior rectal resection; RLAR  robot-assisted anterior rectal resection.
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respectively.
A total of 4 patients in the TLAR group (6% of the total
patients) are alive with metastatic disease and/or local
recurrence. One patient at 47 months after surgery was
palliated with bowel stenting and radiotherapy for
local recurrence and carcinosis. One patient has brain
and adrenal metastases, and in the third the CT scan
showed local recurrence and multiple liver and lung
metastases in rapid progression under chemotherapy.
The fourth patient underwent robot-assisted TME for
local recurrence 8 months after a traditional laparo-
scopic PME.
No differences were observed in overall and disease-free
survival, but we found a trend towards a better disease-
free survival in the RLAR group (Figure 2).
DISCUSSION
Application of robotics to the treatment of rectal cancer
has been demonstrated to be feasible in recent studies
highlighting technical advantages brought about by the da
Vinci System in TME.9–11
The general advantages of this robotic system are a 3-di-
mensional view, hand-tremor filtering, fine dexterity, and
motion scaling, providing an absolute benefit when the
operative field is narrow and fixed and sharp dissection is
necessary. Despite the subjective experience of the sur-
geon at the console being impressive, to date there are no
comparative studies demonstrating a real impact of this
technology on patient outcome.5
To the best of our knowledge, this is the first study
comparing RLAR and TLAR. We are well aware of the
intrinsic limitations of the study. After a few cases, we
Table 2.
Intraoperative and Pathologic Data
TLAR* RLAR* P Value
Type of Proctectomy* 0.05
PME 24 3
TME 8 18
APR 3 5
CAA 2 5
Operative Times (minutes)
Total 208  7 202  12 0.05
PME 217  6 270  67 0.05
TME 210  37 165.9  10 0.05
APR 285  21 213  2 0.05
CAA 240-360 228  32
Estimated Blood Loss (mL) 127  169 137.4  156 0.05
Conversion to Open Surgery 7 0 0.05
Distal Margin (cm) 4.5  7.2 2.1  0.9 0.05
Radial Margin Negative Negative
Nodes Retrieved 11.2  5 10.3  4 0.05
Concomitant Procedures 1 Robot-assisted wedge liver resection; 1 Robot-assisted wedge liver resection
1 Wedge bladder resection; 1 Right colectomy
1 Cholecystectomy; 1 Vaginal resection
1 Adhesiolysis 1 Adhesiolysis
*TLAR  traditional laparoscopic anterior rectal resection; RLAR  robot-assisted anterior rectal resection; PME  partial mesorectal
excision; TME  total mesorectal excision; APR  Abdominoperineal resection; CAA  intersphinteric resection with coloanal
anastomosis.
Short- and Medium-Term Outcome of Robot-Assisted and Traditional Laparoscopic Rectal Resection, Patriti A et al
JSLS (2009)13:176–183 180preferred to treat all patients with low rectal cancer with a
robotic approach mismatching the 2 groups, the mean
follow-up time is not appropriate to give definitive results
on oncologic outcome, and the series is small for a pow-
erful statistical analysis. Nevertheless, because the short-
term results were surprising with respect to operative time
and conversion rate, it was decided that publication of
these results would be of interest. On the other hand,
what from a statistical point of view is a bias can be
considered a point of strength of the study. In fact, out-
come results have to be weighted on the major complexity
of the procedures performed in a robot-assisted approach.
The majority of patients in the RLAR group had previous
abdominal surgery and low rectal cancer requiring a TME.
In addition, in the RLAR group, more patients underwent
neo-adjuvant chemoradiation in respect to the TLAR and
OAR groups. Our study indicates for the first time that
robot-assisted TME can be performed in a significantly
shorter operative time compared with TLAR and with a
lower conversion rate. Distal and radial margins were
tumor-free in all cases as obtained in the TLAR group. The
mean number of harvested nodes was comparable as
well. These data demonstrate that RLAR respects oncolog-
ical criteria for mesorectal excision and improve surgical
maneuvers, reducing operating times.
On the contrary, no advantages in terms of subjective and
objective results were obtained in PME. In cases of high
rectal tumors, RLAR results in longer operating times.
These data rely on the easy execution of PME during
Table 3.
Outcomes
TLAR RLAR P Value
Hospital Stay (days) 9.6  6.9 (5-37) 11.9  7.5 (6-29) 0.05
30 Days Morbidity
Anastomotic leak 1 (2.7%) 2 (6.8%) 0.05
Wound infection 2 (5.4%) 1 (3.4%) 0.05
Hemorrhage 2 (5.4%) 1 (3.4%) 0.05
Prolonged ileus 1 (2.7%) 2 (6.8%) 0.05
Urinary retention 1 (2.7%) 1 (3.4%) 0.05
Enteritis 0 2(6.8%) 0.05
Overall 18.9% 30.6% 0.05
Follow-up Time (months) 18.7  13.8 29.2  14 0.05
Long-term Morbidity
Erectile dysfunction† 3 (16.6%) 1 (5.5%) 0.05
Faecal incontinence 1 (2.7%) 2 (6.8%) 0.05
Constipation 3 (8.1%) 4 (13.7%) 0.05
Incisional hernia 2 (5.4%) 0 0.05
Overall 32.8% 26% 0.05
†In male population.
*TLAR  traditional laparoscopic anterior rectal resection; RLAR  robot-assisted anterior rectal resection.
Figure 2. Disease-free survival curves. Robot-assisted anterior
rectal resection: continuous line. Traditional laparoscopic ante-
rior rectal resection: interrupted line.
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the plane of dissection above the inferior mesenteric ar-
tery over the sacral promontory. This maneuver is greatly
facilitated in laparoscopy by pneumodissection, and we
do not believe that robotics could further improve it.
Perhaps, studies comparing a totally robot-assisted and
totally laparoscopic PME are needed to validate this im-
pression. Regarding complications and postoperative out-
come, both minimally invasive approaches resulted in a
comparable early postoperative course. No differences
were reported between groups in the incidence of sexual
dysfunction, even if its expected frequency in the RLAR
group is higher than that observed due to the larger
amount of low rectal tumors.12,13
Survival curve analysis revealed no differences between
the 2 groups, but a trend towards a better disease-free
survival was highlighted in the RLAR group. Notably, in
the RLAR group, there are not local recurrences during the
follow-up period. This result can be explained by a dif-
ferent tumor response to adjuvant chemotherapy or to an
increasing number of neoadjuvant therapies in the RLAR
group, but possible improvement in local disease control
by robotic dissection is also a reasonable possibility. Im-
age magnification and 3-dimensional vision could be re-
sponsible for this result as a consequence of the fine
dissection and the easier identification of the cleavage
planes also in a narrow pelvis.
This observation, if confirmed in randomized controlled
trials, could dramatically change the standard approach to
rectal cancer.14 Coupled with better local control, a min-
imally invasive procedure could accelerate the beginning
of adjuvant treatments by reducing complications and
patient discomfort. As a matter of fact, laparoscopic colo-
rectal resection is associated with a better early outcome
than that of traditional open surgery.15,16
It is convincing that a better postoperative course could
itself be a factor in improving survival of patients with
advanced disease requiring early postoperative chemo-
therapy.17–19
In our series, both RLAR and TLAR patients underwent
planned postoperative chemoradiation without delay.
Therefore, robot-assisted TME could allow an increasing
number of patients with low rectal cancer to benefit from
the intrinsic advantages of minimally invasive surgery.
Unfortunately, in our study the length of stay cannot be
used as a discriminating factor of a better early outcome.
Indeed, in Italy the healthcare delivery system does not
give patients any financial incentives to be discharged
early. The general attitude is to discharge patients in
relation to the absence of complications, tolerance of a
normal diet, and patient preference.
CONCLUSION
Despite the fact that the limitations of the study do not
permit definitive results, robotics is likely to improve lapa-
roscopic TME but not PME. Future prospective controlled
studies should be aimed at verifying whether robotic TME
might increase local control of rectal cancer, disease-free
patient survival, and postoperative sexual function in male
patients. If confirmed, our data suggest the possibility for
a tailored approach to rectal cancer with a predominant
role for robotics for lower cancer treatment and a re-
stricted use of traditional laparoscopy to cancers requiring
PME.
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